Robecosam AG increased its position in Constellium NV (NYSE:CSTM) by 29.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,400,000 shares of the industrial products company’s stock after acquiring an additional 320,000 shares during the period. Robecosam AG owned about 1.33% of Constellium worth $15,960,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently modified their holdings of CSTM. BlackRock Inc. lifted its position in Constellium by 2,011.0% during the fourth quarter. BlackRock Inc. now owns 2,154,669 shares of the industrial products company’s stock valued at $24,025,000 after purchasing an additional 2,052,599 shares in the last quarter. Monarch Partners Asset Management LLC purchased a new position in Constellium during the fourth quarter valued at $16,219,000. Boussard & Gavaudan Investment Management LLP lifted its position in Constellium by 79.9% during the fourth quarter. Boussard & Gavaudan Investment Management LLP now owns 2,719,822 shares of the industrial products company’s stock valued at $30,054,000 after purchasing an additional 1,207,612 shares in the last quarter. Governors Lane LP lifted its position in Constellium by 97.9% during the fourth quarter. Governors Lane LP now owns 2,275,288 shares of the industrial products company’s stock valued at $25,369,000 after purchasing an additional 1,125,288 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership lifted its position in Constellium by 104.5% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 1,273,650 shares of the industrial products company’s stock valued at $14,201,000 after purchasing an additional 650,706 shares in the last quarter. 80.66% of the stock is owned by institutional investors.
CSTM has been the topic of several analyst reports. Morgan Stanley upgraded Constellium from an “equal weight” rating to an “overweight” rating in a research report on Thursday, November 16th. Cowen set a $20.00 target price on Constellium and gave the company a “buy” rating in a research report on Tuesday, February 6th. ValuEngine upgraded Constellium from a “hold” rating to a “buy” rating in a research report on Friday, February 2nd. Finally, Societe Generale downgraded Constellium from a “buy” rating to a “hold” rating in a research report on Wednesday, February 28th. Five equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Constellium currently has an average rating of “Hold” and an average target price of $14.25.
Constellium (NYSE:CSTM) last announced its quarterly earnings data on Thursday, February 22nd. The industrial products company reported ($0.77) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.10 by ($0.87). Constellium had a negative net margin of 0.66% and a negative return on equity of 5.81%. The business had revenue of $1.25 billion during the quarter, compared to analysts’ expectations of $1.28 billion. During the same quarter in the previous year, the firm earned ($0.19) earnings per share. Constellium’s revenue was up 7.5% on a year-over-year basis. equities research analysts predict that Constellium NV will post 1.1 EPS for the current year.
Constellium Company Profile
Constellium N.V. is a Netherlands-based company engaged in developing aluminum products for a range of markets and applications, including aerospace, automotive and packaging. The Company’s manufacturing facilities are located in the United States, Europe and China. It operates through three segments: Packaging & Automotive Rolled Product; Aerospace & Transportation, and Automotive Structures & Industry.
Want to see what other hedge funds are holding CSTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Constellium NV (NYSE:CSTM).
Receive News & Ratings for Constellium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Constellium and related companies with MarketBeat.com's FREE daily email newsletter.